Suspected KITD816V Mutated Clonal Mast Cell Disease

1

Review clinical trials related to Suspected KITD816V Mutated Clonal Mast Cell Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.

Participants needed: 450
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Blueprint Medicines CorporationUpdated: Jun 25, 2026Locations: 19
Eligibility criteria

Documented anaphylaxis due to Hymenoptera venom with cardiovascular symptoms or [+7]

Monoclonal mast cell activation syndrome with a known KIT mutation [+4]